TY - CHAP
T1 - Cystinosis and its renal complications in children
AU - Gahl, William A.
AU - Nesterova, Galina
N1 - Publisher Copyright:
© Springer-Verlag Berlin Heidelberg 2009, 2016.
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Nephropathic cystinosis [1–3] deserves a special place in the annals of clinical medicine as the first treatable lysosomal storage disease. The pathophysiology itself, based upon the formation of cystine crystals within the lysosomes of cells, is remarkable. The presence of cystine crystals provides a clue to the basic defect in cystinosis, i.e., failure to transport cystine out of lysosomes [4–6]. This created a new area of biomedical investigation, explained the lysosome’s function in salvaging small molecules for reutilization by the cell, and revealed a new category of lysosomal storage disorders due to transport defects rather than enzyme deficiencies [7]. Even more striking, a rational therapy of cystine depletion (i.e., cysteamine) emerged [8–10], transforming nephropathic cystinosis from a universally fatal disease to a treatable chronic disorder with a decent quality of life and increased life span. Today, physicians can even observe the gradual dissolution of cystine crystals by cysteamine eyedrops bathing the corneas of patients’ eyes [11–13].
AB - Nephropathic cystinosis [1–3] deserves a special place in the annals of clinical medicine as the first treatable lysosomal storage disease. The pathophysiology itself, based upon the formation of cystine crystals within the lysosomes of cells, is remarkable. The presence of cystine crystals provides a clue to the basic defect in cystinosis, i.e., failure to transport cystine out of lysosomes [4–6]. This created a new area of biomedical investigation, explained the lysosome’s function in salvaging small molecules for reutilization by the cell, and revealed a new category of lysosomal storage disorders due to transport defects rather than enzyme deficiencies [7]. Even more striking, a rational therapy of cystine depletion (i.e., cysteamine) emerged [8–10], transforming nephropathic cystinosis from a universally fatal disease to a treatable chronic disorder with a decent quality of life and increased life span. Today, physicians can even observe the gradual dissolution of cystine crystals by cysteamine eyedrops bathing the corneas of patients’ eyes [11–13].
UR - http://www.scopus.com/inward/record.url?scp=84957623141&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84957623141&partnerID=8YFLogxK
U2 - 10.1007/978-3-662-43596-0_37
DO - 10.1007/978-3-662-43596-0_37
M3 - Chapter
AN - SCOPUS:84957623141
SN - 9783662435953
SP - 1329
EP - 1353
BT - Pediatric Nephrology, Seventh Edition
PB - Springer Berlin Heidelberg
ER -